Alnylam's Q2 Revenues Soar as Losses Decline; Firm Gives Update on Pipeline, microRNA Work

Alnylam's Q2 Revenues Soar as Losses Decline; Firm Gives Update on Pipeline, microRNA Work
By Doug Macron
July 27, 2006
RNAi News
The company remains on track to sign two more out-licensing deals for its IP in the research field before year end, bringing the total number of licensees for the year to five.
Paid subscription is required to view article.
Comments: 0
Votes:17